Percutaneous pulmonary valve replacement: Autologous tissue-engineered valved stents

Cardiovascular Research

Volumn 88, Issue 3, 2010, Pages 453-461

  Metzner, Anja ^a   Stock, Ulrich A ^b   Iino, Kenji ^a   Fischer, Gunther ^a   Huemme, Tim ^a   Boldt, Jessica ^a   Braesen, Jan Hinrich ^a   Bein, Berthold ^a   Renner, Jochen ^a   Cremer, Jochen ^a   Lutter, Georg ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Percutaneous implantation; Tissue engineering

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; NITINOL; VON WILLEBRAND FACTOR;

ANGIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY STENT; ENDOTHELIUM CELL; FOLLOW UP; HEART VALVE REPLACEMENT; HISTOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; JUVENILE ANIMAL; LEYDIG CELL; MYOFIBROBLAST; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY VALVE; RADIOGRAPHY; SLAUGHTERHOUSE; SMALL INTESTINE MUCOSA; TISSUE ENGINEERING;

ALLOYS; ANGIOGRAPHY; ANIMALS; CELLS, CULTURED; ECHOCARDIOGRAPHY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; INTESTINAL MUCOSA; MODELS, ANIMAL; MYOFIBROBLASTS; PULMONARY VALVE; SHEEP; STENTS; SWINE; TISSUE ENGINEERING; TRANSPLANTATION, HETEROLOGOUS;

EID: 78149286862     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq212     Document Type: Article

References (28)

1. Frigiola A, Redington AN, Cullen S, Vogel M. Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot. Circulation 2004;110(suppl.):II153-II157.
2. Meyns B, Van Garsse L, Boshoff D, Eyskens B, Mertens L, Gewillig M et al. The Con-tegra conduit in the right ventricular outflow tract induces supravalvular stenosis. J Thorac Cardiovasc Surg 2004;128:834-840.
3. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003;23:1002-1006.
4. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-arteryprosthetic conduit with valve dysfunction. Lancet 2000;356:1403-1405.
5. Bonhoeffer P, Boudjemline Y, Saliba Z, Hausse AO, Aggoun Y, Bonnet D et al. Trans-catheter implantation of a bovine valve in pulmonary position. Circulation 2000;102: 813-816.
6. Stock UA, Degenkolbe I, Attmann T, Schenke-Layland K, Freitag S, Lutter G. Prevention of device-related tissue damage during percutaneous deployment of tissue-engineered heart valves. J Thorac Cardiovasc Surg 2006;131:1323-1330.
7. Attmann T, Jahnke T, Quaden R, Boening A, Muller-Hulsbeck S, Cremer J et al. Advances in experimental percutaneous pulmonary valve replacement. Ann Thorac Surg 2005;80:969-975. (Pubitemid 41196795)
8. Attmann T, Quaden R, Jahnke T, Muller-Hulsbeck S, Boening A, Cremer J et al. Percutaneous pulmonary valve replacement: 3-month evaluation of self-expanding valved stents. Ann Thorac Surg 2006;82:708-714.
9. Nerem RM. Cellular engineering. Ann Biomed Eng 1991;19:529-545.
10. Lurz P, Coats L, Khambadkone S, Nordmeyer S, Boudjemline Y, Schievano S et al. Percutaneous pulmonary valve implantation impact of evolving technology and learning curve on clinical outcome. Circulation 2008;117:1964-1972.
11. Dearani JA, Danielson GK, Puga FJ, Schaff HV, Warnes CW, Driscoll DJ et al. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg 2003;75:399-410.
12. Hawkins JA, Breinholt JP, Lambert LM, Fuller TC, Profaizer T, McGough EC et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Surg 2000;119:324-330.
13. da Costa FD, Dohmen PM, Duarte D, von Glenn C, Lopes SV, Filho HH et al. Immunological and echocardiographic evaluation of decellularized versus cryopre-served allografts during Ross operation. Eur J Cardiothorac Surg 2005;27:572-578.
14. Lichtenberg A, Tudorache I, Cebotari S, Sturz G, Goerler H, Ringes-Lichtenberg S et al. Preclinical testing of tissue engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 2005;112:572-578.
15. Rüffer A, Purbojo A, Cicha I, Glöckler A, Potapov S, Dittrich S et al. Early failure of xenogenous de-cellularised pulmonary valve conduits\-a word of caution. Eur J Car-diothorac Surg 2010;38:78-85.
16. Schievano S, Migliavacca F, Coats L, Khambadkone S, Carminati M, Wilson N et al. Percutaneous pulmonary valve implantation based on rapid prototyping of right ventricular outflow tract and pulmonary trunk from MR data. Radiology 2007;242: 490-497. (Pubitemid 46146202)
17. Schievano S, Taylor AM, Capelli C, Coats L, Walker F, Lurz P et al. First-in-man implantation of a novel percutaneous valve: a new approach to medical device development. EuroIntervention 2010;5:745-750.
18. Iop L, Renier V, Naso F, Piccoli M, Bonetti A, Gandaglia A et al. The influence of heart valve leaflet matrix characterisation the interaction between human mesenchymal stem cells and decellularized scaffolds. Biomat 2009;30:4104-4116.
19. Shcherbo D, Merzylak EM, Chepurnykh TV, Fradkov AF, Ermakova GV, Solovieva EA et al. Bright far-red fluorescent protein for whole-body imaging. Nat Methods 2007;4: 741-746.
20. Schenke-Layland K, Opitz F, Gross M, Döhring C, Halbhuber KJ, Schirrmeister F et al. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals\-an in vitro study. Cardiovasc Res 2003;60:497-509.
21. Gross JM. Calcification and bioprosthetic heart valves and its assessment. J Thorac Car-diovasc Surg 2003;125:6-8.
22. Cebotari S, Lichtenberg A, Tudorache I, Hilfiker A, Mertsching H, Leyh R et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006;114(Suppl. I):I-132-I-137.
23. Schenke-Layland K, Riemann I, Opitz F, König K, Halbhuber KJ, Stock UA. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol 2004;23:113-125.
24. Rieder E, Seebacher G, Kasimir MT, Eichmair E, Winter B, Dekan B et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005;111: 2792-2797.
25. Schleicher M, Wendel HP, Fritze O, Stock UA. In vivo tissue engineering of heart valves: evolution of a novel concept. Regen Med 2009;4:613-619.
26. Metzner A, Iino K, Steinseifer U, Uebing A, de Buhr W, Cremer J et al. Percutaneous pulmonary polyurethane valved stent implantation. J Thorac Cardiovasc Surg 2010;139: 748-752.
27. Horvath KA, Mazlin D, Guttmann M, Zetts A, Hunt T, Li M. Midterm results of trans-apical aortic valve replacement via real-time magnetic resonance imaging guidance. J Thorac Cardiovasc Surg 2010;139:424-430.
28. Hung J, Lang R, Flachskampf F, Shernan SK, McCulloch ML, Adams DB et al. 3D-echocardiography: a review of the current status and future directions. J Am Soc Echocardiogr 2007;20:213-233.